01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#ELEG Electric Guitar PLC – Shareholdings and total voting rights August 28, 2024 – Posted in: Electric Guitar Plc (ELEG)

Electric Guitar PLC (LSE: ELEG), the digital marketing and advertising company providing first-party data solutions, has been informed that with the issue of 9,834,521 ordinary shares of 0.5p each in the Company pursuant to the acquisition of Mymyne Limited announced on 9 August 2024 (“Initial Consideration Shares”) and their admission to trading on AIM today, two directors of the Company have received Initial Consideration Shares in the Company as announced on 9 August 2024 and…

Continue reading

#TSP TruSpine Technologies PLC – Convertible Loan Note Extension & RPT July 24, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, that further to the announcement on 28 March 2024, the Company has extended the maturity date of the convertible loan note (“CLN”) to 30 June 2025. All other terms of the CLN remain unchanged. Related Party Transaction The extension of maturity date of the CLN (the “Transaction”) is a related party transaction for the purposes of Rule 4.6 of the AQSE…

Continue reading

#TSP TruSpine PLC – Further re: FDA Update October 12, 2023 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces that, further to the announcement on 3 October 2023, the Company has submitted additional documentation and provided further clarification in regard to the questions raised by the U.S. Food and Drug Administration (“FDA”) relating to the Company’s FDA 510(k) application. TruSpine CEO Laurence Strauss commented: “We are pleased the US FDA have responded…

Continue reading